6Q7N
Crystal structure of BH32 alkylated with the mechanistic inhibitor 2-bromoacetophenone
Summary for 6Q7N
Entry DOI | 10.2210/pdb6q7n/pdb |
Descriptor | BH32, 1-PHENYLETHANONE (3 entities in total) |
Functional Keywords | computationally designed enzyme, hydrolase |
Biological source | Pyrococcus horikoshii |
Total number of polymer chains | 1 |
Total formula weight | 27796.77 |
Authors | Levy, C.W. (deposition date: 2018-12-13, release date: 2019-06-05, Last modification date: 2024-10-16) |
Primary citation | Burke, A.J.,Lovelock, S.L.,Frese, A.,Crawshaw, R.,Ortmayer, M.,Dunstan, M.,Levy, C.,Green, A.P. Design and evolution of an enzyme with a non-canonical organocatalytic mechanism. Nature, 570:219-223, 2019 Cited by PubMed Abstract: The combination of computational design and laboratory evolution is a powerful and potentially versatile strategy for the development of enzymes with new functions. However, the limited functionality presented by the genetic code restricts the range of catalytic mechanisms that are accessible in designed active sites. Inspired by mechanistic strategies from small-molecule organocatalysis, here we report the generation of a hydrolytic enzyme that uses N-methylhistidine as a non-canonical catalytic nucleophile. Histidine methylation is essential for catalytic function because it prevents the formation of unreactive acyl-enzyme intermediates, which has been a long-standing challenge when using canonical nucleophiles in enzyme design. Enzyme performance was optimized using directed evolution protocols adapted to an expanded genetic code, affording a biocatalyst capable of accelerating ester hydrolysis with greater than 9,000-fold increased efficiency over free N-methylhistidine in solution. Crystallographic snapshots along the evolutionary trajectory highlight the catalytic devices that are responsible for this increase in efficiency. N-methylhistidine can be considered to be a genetically encodable surrogate of the widely employed nucleophilic catalyst dimethylaminopyridine, and its use will create opportunities to design and engineer enzymes for a wealth of valuable chemical transformations. PubMed: 31132786DOI: 10.1038/s41586-019-1262-8 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.02 Å) |
Structure validation
Download full validation report